NASDAQ · NHTC

Natural Health Trends Corp.

$1.90 +$0.10 (+5.56%) 1D After hours

Key Metrics

$15.44M
Market cap
P/E · TTM
$38.25M
Revenue · TTM
−$1.16M
Net income
EPS · TTM $-0.10
Dividend yield 50.3%
Free cash flow −$7.45M
Beta · 1Y 0.87
EBITDA · TTM −$776.00K
Gross margin 73.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 26
    From its Feb 4 high, the share price fell 61%.

    Peak close $4.00 on Feb 4; trough close $1.55 on Jun 26. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -61%
  • Jun 12
    The stock moved -15.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 12
  • Feb 17
    The stock moved -11.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$15.44M
Enterprise value
Shares outstanding8.6M
52-wk range$1.55 – $5.10
Avg volume · 20D24.7K
Net cash
Book value / share$1.43
IndustryWholesale-Miscellaneous Nondurable Goods
ExchangeNASDAQ
About Natural Health Trends Corp.
IPO dateJun 22, 1995
Employees120

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.40
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 73.9%
Operating -2.3%
Net -3.0%
FCF -19.5%
ROE / ROIC -4.7% · 24.3%

Financial Health

Current ratio2.00
Quick ratio1.85
Debt / equity
Debt / EBITDA
Net cash
Working capital$13.29M

Cash Flow · TTM

Operating CF −$7.28M
Capex −$167.00K
Free cash flow −$7.45M
Buybacks
Dividends paid $7.77M
Shareholder yield 50.3%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

0.6
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings